On July 9, 2025, Citigroup analyst Joanne Wuensch maintained a "Buy" rating for GE HealthCare Techs (GEHC, Financial) while raising the price target. The updated price target stands at $89.00, up from the previous target of $86.00.
This adjustment reflects a 3.49% increase in the price target for GEHC, as reported by Citigroup. The decision to uphold the "Buy" rating signifies confidence in the company’s potential performance.
The previous evaluation of GE HealthCare Techs by Citigroup had also positioned the stock with a "Buy" rating, demonstrating consistent support from the financial institution.
The revised price target and rating were issued in US dollars (USD) and are aimed at investors closely monitoring GEHC's market movements and prospects.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 18 analysts, the average target price for GE HealthCare Technologies Inc (GEHC, Financial) is $87.02 with a high estimate of $106.00 and a low estimate of $73.00. The average target implies an upside of 15.48% from the current price of $75.36. More detailed estimate data can be found on the GE HealthCare Technologies Inc (GEHC) Forecast page.
Based on the consensus recommendation from 20 brokerage firms, GE HealthCare Technologies Inc's (GEHC, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
